{"id":"NCT01667562","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","officialTitle":"Phase IIIb, Open-Label Study of Erlotinib (TarcevaÂ®) Treatment in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Present Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01-20","primaryCompletion":"2017-09-07","completion":"2017-09-07","firstPosted":"2012-08-17","resultsPosted":"2019-12-20","lastUpdate":"2019-12-20"},"enrollment":375,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non-Small Cell Lung Cancer"],"interventions":[{"type":"DRUG","name":"Erlotinib","otherNames":["Tarceva"]}],"arms":[{"label":"Erlotinib","type":"EXPERIMENTAL"},{"label":"Diagnostic Phase","type":"NO_INTERVENTION"}],"summary":"This open-label, multi-center study will evaluate the progression-free survival and safety of erlotinib in participants with locally advanced or metastatic non-small cell lung cancer with activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR). Participants will receive daily oral doses of erlotinib until disease progression or unacceptable toxicity.","primaryOutcome":{"measure":"Progression-Free Survival as Assessed by Response Evaluation Criteria in Solid Tumors (RECIST) Version 1.1 (v 1.1)","timeFrame":"Baseline until disease progression, or death, whichever occurs first (approximately up to 4 years and 9 months)","effectByArm":[{"arm":"Erlotinib","deltaMin":9.574,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":10},"locations":{"siteCount":4,"countries":["Serbia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":30},"commonTop":["Rash","Fatigue","Anemia","Dyspnea","Diarrhea"]}}